Percutaneous image-guided biopsy plays an integral role in the management of breast lesions identified on imaging studies, with reported rates of up to 1%-8% of women enrolled in a screening mammography program undergoing percutaneous breast biopsy at some point in their care [1, 2] . Depending on the characteristics of the lesion, biopsy techniques may vary in the type (ie, fine-needle aspiration [FNA] , core needle [CNB] , vacuum-assisted [VAB] ) and in the modality used for imaging guidance (ultrasound [US], mammography, magnetic resonance imaging [MRI] ). As with any invasive procedure, it is important to try to minimize the patient's overall discomfort and pain perception, and recognize what factors may contribute to this, especially as pain and discomfort may affect future adherence to screening [3] .
Although a commonly performed procedure, previously published literature regarding the impact of various factors during image guided breast biopsy on the pain experience is scarce and somewhat discrepant. Pain scores were found to be operator-dependent by Denton et al [4] , and more specifically operator experience showed an inverse correlation with pain scores in the study by Salem et al [5] . However several other studies did not demonstrate any influence on pain scores by operator [6, 7] or their level of training [8] .
Studies stratifying results by imaging modality and biopsy method have also been few and their conclusions variable. Satchithanada et al [7] reported that FNA was associated with significantly increased pain scores while Denton et al [4] did not report such an association. Additionally, no prior published studies have examined pain associated with MRIguided biopsies. There is also little consensus with regards to the influence of age, breast density, and final pathology.
The aim of our study was to evaluate the pain experienced by patients undergoing image-guided breast biopsy, and examine the association between pain and factors that included biopsy type, image guidance method, needle gauge, and preprocedural anxiety. Because of the relatively large number of trainees that rotate through the department and the emerging usage of MRI-guided biopsies, the analysis included data on operator experience and MR-guidance.
Materials and Methods

Participants
Between December 2012 and May 2013, 391 patients undergoing image-guided breast biopsy across 3 teaching hospitals agreed to participate in a quality assurance survey designed to characterize intraprocedural pain. Participation in the survey was voluntary and involved answering questions immediately prior to and following the biopsy procedure. Of the 391 who completed questionnaires, 31 were excluded due to missing data. This resulted in a final population of 360 described in the current study, which did not use personal identifiers. Research ethics approval was not required for this study because it was considered a quality assurance study under the 2014 Tri-Council Policy Statement.
Biopsy Procedure
Image guidance used either US with a high-frequency linear probe, mammography/stereotactic guidance, or MRI.
Using aseptic technique, biopsies were performed using needles ranging from 18-22 gauge (FNA), 14 gauge (CNB), or 9-12 gauge (VAB). Local anesthetic (1% lidocaine) was routinely used for CNB and VAB, and variably for FNA depending on operator preference.
Data Collection Process
Upon providing consent for the standard of care biopsy, patients were asked by technologists if they wished to participate in a survey. They were provided a 1-page information sheet that explained the purpose of the survey, that it was voluntary and would not impact their care, and what participation would entail. The survey included 2 items to be completed prior to the biopsy and items to be completed immediately following the procedure while in the biopsy room. Technologists assisting in the biopsy procedure completed a data collection form with biopsy details that included biopsy methods and operator details.
Data Procedure
Technologists recorded details related to the biopsy, including guidance method (mammography, US, MRI), biopsy method (FNA, VAB, CNB), needle gauge, local anesthetic used, and operator performing the biopsy (including level of training).
Prebiopsy
Prior to the biopsy, patients were asked to indicate their anxiety (0-10), and rated their average pain ''during the past few weeks'' using the Numeric Rating Scale (NRS; 0-10) [9] .
Postbiopsy
Following the biopsy, patients completed a survey that included items scoring the worst pain experienced during the biopsy procedure (NRS), location of the worst pain, and whether this was their first breast biopsy.
Statistical Analysis
Pain scores were analyzed in their raw numeric (0-10) and categorized format (0, none; 1-3, mild; 4-6, moderate; 7-10, severe). Descriptive statistics were used to analyze patient characteristics, pain scores and procedural details. The Kruskal-Wallis (raw numeric) and chi-square tests (categorized format) were used to examine associations between biopsy variables and reported pain scores. The Spearman correlation coefficient (r) was calculated to examine the association between prebiopsy anxiety and biopsy pain. For all analyses, a P value <.05 was considered evidence of a statistically significant association.
Results
There were a total of 360 survey respondents included in the current study (Table 1) . Of these, 40 (11%) had mammographically guided biopsies, 298 (83%) were US guided, and 22 (6%) were MRI guided. When sorting by biopsy method, there were 20 FNAs, 54 VAB, and 286 CNB with the majority of FNA and CNB under US guidance and the VAB divided between mammography and MRI guidance. 58% of patients reported the current breast biopsy as their first, while 239 (68%) biopsies were performed by staff radiologists.
Combining all biopsies, 69 patients (19%) reported no pain, 171 (48%) reported mild pain, 93 (26%) moderate pain, and 27 (8%) severe pain. Pain scores specifically divided by guidance method and by technique are summarized in the tables below (Tables 2 and 3 ). Of the 3 guidance methods, Values are mean AE SD or n (%).
patients who had MRI-guided biopsies reported slightly higher pain scores (mean NRS, 4.3) compared to US (mean NRS, 2.5) and mammography (mean NRS, 3.5). MRI-guided biopsy patients were also more likely to report moderate to severe pain (64% vs 30% for US and 42% for mammography). A comparison of pain scores between modalities revealed significant differences between US and MRI (P ¼ .001) and mammography (P ¼ .007) but not between MRI and mammography (P ¼ .193). Correlation between scores in these patients was moderate to strong. The correlation of preprocedural anxiety (r ¼ 0.244) and history of previous biopsies also were not found to be associated with pain scores (P ¼ .201) in the overall group. With regard to biopsy technique, there was a statistically significant association between pain scores and biopsy method (Table 3 ; P ¼ .016).
There was a weak inverse association between pain scores and operator experience; the mean pain scores for procedures performed by staff, fellows, and residents were 2.6 (SD, 2.2), 2.9 (SD, 2.2), and 3.3 (SD, 2.4), respectively ( Figure 1) . The overall differences, however, were not statistically significant (P ¼ .142).
Discussion
Our results indicate that a large majority of patients reported no or mild pain during their biopsy procedure; the mean pain for all biopsies was 2.7 (SD, 2.3), with only 8% of patients reporting severe pain (defined as an NRS score !7). This is consistent with previous literature with patients reporting average pain scores of less than 4 or mild pain depending on the rating system used [4, 5, 7, 10, 11] . Previous biopsy experience and preprocedural anxiety did not seem to affect pain scores to a considerable degree.
To our knowledge, no prior studies have looked specifically at differences between imaging guidance modality and pain scores. It is to be noted that the vast majority of US-guided biopsies are CNB and FNA, all MRI-guided biopsies are VAB, and stereotactic biopsies are divided between CNB and VAB at our institution. US guidance demonstrated statistically lower pain scores compared to other guidance methods (2.5; SD, 2.2). Further, there is minimal variability in needle size used for each biopsy method, which results in needle gauge being a proxy for modality and method.
When comparing all biopsies, MRI absolute pain scores were higher and patients were more likely to report moderate to severe pain (NRS !4) compared to other guidance methods. However, the differences in pain scores were found to be statistically significant only when US and MRI were compared. This may be due to both mammography and MRI methods requiring compression, nonsupine positioning and generally longer procedure duration compared to US. Differences between stereotactic and MRI pain scores, although small, may be related to increased procedure time for MRI and slight positional differences affecting the pain experience. We also note that overall small numbers of MRI-guided biopsies limit any strong conclusions that can be drawn.
A review of previous studies examining the effect of biopsy method yielded variable results. Satchithanada et al [7] found significantly higher pain scores with FNA compared to both CNB and VAB, with the latter 2 not differing significantly. Conversely, Zogouri et al [12] found that core biopsy resulted in higher pain scores than FNA and Szynglarewicz et al [10] found CNB to score higher than VNB. Denton et al [4] did not describe significant differences between US guided FNA, CNB, and stereotactic VAB. The findings of the (7e10) 7 (17) 17 (6) 3 (14) Values are mean AE SD or n (%). Overall: P < .001 (Kruskal-Wallis, numeric), P ¼ .001 (chi square, categorical). Mammography vs magnetic resonance imaging (MRI): P ¼ .193; Mammography vs ultrasound (US): P ¼ .007; MRI vs US: P ¼ .001. current study would seem to support both Zogouri et al [12] and Szynglarewicz et al [10] , with FNA, CNB, and VAB found to be in order from least to most painful.
The current study also showed no significant difference in pain scores by operator level of training. This is supported by Soo et al [8] , with other studies not specifying radiology trainees as a separately analyzed group. With the department performing biopsies across a 3 tertiary care university hospitals, a large number of trainees are hosted. These trainees are members of either the university medical imaging residency program or a fellowship program that includes a wide spectrum of Canadian and international fellows. During their rotation through the department, the trainees receive graded supervision based on their prior experience and abilities to perform image-guided breast intervention. They are initially encouraged to practice on a simulated turkey breast phantom followed by a closely supervised step-by-step biopsy procedure. Upon obtaining satisfactory competency, they are allowed to independently perform procedures.
The major limitation to the current study was that the data was collected as part of a quality assurance initiative designed to be brief, conducted with minimal interference to patient flow or collection of personal identifiers. As such, we were unable to control for or document details such as the specific brand of guidance device, psychosocial factors, anesthesia dose or breast density. There were few cases where local anesthesia was not used (usually in FNA cases with small needle gauge or patient allergy), which limited conclusions that can be drawn regarding the use of anesthesia.
There were also a relatively small numbers of MRI-guided biopsies included in the study, which leads to decreased statistical power and precludes strong conclusions regarding this guidance method. Although radiologist experience may be inversely correlated with pain, MRI-guided breast biopsies have been performed in our department since 2007 and all staff radiologists were considered to have performed a sufficient number of such biopsies prior to commencement of this study to be considered experienced. Similarly, we realize that the relatively small number of procedures performed by staff may have contributed to the results, and cannot exclude the potential for more difficult cases to have been performed by staff, especially those in patients who were perceived to have high levels of preprocedural anxiety.
Despite these limitations, the current study involved a large overall number of patients, and included those undergoing MRI-guided procedures. The biopsies were also performed by operators with a wide range of experience, which is often the case in specialty centers that host and supervise trainees.
The results of the current study suggest that breast biopsies do not result in significant patient pain or discomfort in most cases, and that radiologist can have more flexibility in the selection of biopsy technique and guidance method. This includes allowing trainees to perform procedures under appropriate supervision to gain experience without worrying about increased pain or discomfort to the patient. Increased pain related to MRI guidance was reported, although our numbers are limited. Further studies will need to be performed to further validate and characterize these findings, including the collection of additional technical and psychosocial details.
